Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

2.

Adverse events: past and future.

Ruedy J, Ogilvie RI.

CMAJ. 2004 Sep 14;171(6):549; author reply 550, 552. No abstract available.

3.

Ten-year experience with mission-based budgeting in the faculty of medicine of Dalhousie University.

Ruedy J, MacDonald NE, MacDougall B.

Acad Med. 2003 Nov;78(11):1121-9.

PMID:
14604870
4.

Complementary and alternative medicine: an integrated approach required.

Ruedy J.

Healthc Pap. 2003;3(5):50-5; discussion 72-7.

PMID:
12811077
5.

Methylmercury poisoning.

Ruedy J.

CMAJ. 2001 Oct 30;165(9):1193-4. No abstract available.

6.

Alternative and complementary medicine in Canadian medical schools: a survey.

Ruedy J, Kaufman DM, MacLeod H.

CMAJ. 1999 Mar 23;160(6):816-7. No abstract available.

7.

Undergraduate and postgraduate medical education in Canada.

Gray JD, Ruedy J.

CMAJ. 1998 Apr 21;158(8):1047-50. Review.

8.

Investigator-initiated research: a necessity or a luxury?

Ruedy J.

Clin Invest Med. 1997 Dec;20(6):405-6. No abstract available.

PMID:
9413638
9.

Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease.

Montaner JS, Gill J, Singer J, Raboud J, Arseneau R, McLean BD, Schechter MT, Ruedy J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):153-7.

PMID:
8680886
10.

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.

Pluda JM, Cooley TP, Montaner JS, Shay LE, Reinhalter NE, Warthan SN, Ruedy J, Hirst HM, Vicary CA, Quinn JB, et al.

J Infect Dis. 1995 Jun;171(6):1438-47.

PMID:
7769277
11.

Linking budgets to desired academic outputs at Dalhousie University.

MacDougall B, Ruedy J.

Acad Med. 1995 May;70(5):349-54.

PMID:
7748377
12.

Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.

Wainberg MA, Salomon H, Gu Z, Montaner JS, Cooley TP, McCaffrey R, Ruedy J, Hirst HM, Cammack N, Cameron J, et al.

AIDS. 1995 Apr;9(4):351-7.

PMID:
7540846
13.

Proposed guidelines for housestaff interaction with pharmaceutical companies.

Forrest DM, Ruedy J.

Ann R Coll Physicians Surg Can. 1993 Oct;26(5):291-3.

PMID:
15362243
14.

Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS).

Montaner JS, Guillemi S, Quieffin J, Lawson L, Le T, O'Shaughnessy M, Ruedy J, Schechter MT.

Tuber Lung Dis. 1993 Jun;74(3):173-9.

PMID:
8369511
15.

History of specialty residency funding in Canada.

Ruedy J.

CMAJ. 1993 May 1;148(9):1554-8.

16.

Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT Trial.

Montaner JS, Singer J, Schechter MT, Raboud JM, Tsoukas C, O'Shaughnessy M, Ruedy J, Nagai K, Salomon H, Spira B, et al.

AIDS. 1993 Feb;7(2):189-96.

PMID:
8466681
17.

Teaching of biomedical ethics in postgraduate training programs.

Desjardins J, Kenny NP, Lynch A, Crelinsten GL, Grunberg F, Watts J, Ruedy J.

Ann R Coll Physicians Surg Can. 1992 Aug;25(5):308-12. No abstract available.

PMID:
11651411
18.

Interchangeability of oral contraceptive products.

Ruedy J.

CMAJ. 1992 Jan 15;146(2):108. No abstract available.

19.

Characterization of zidovudine resistant variants of HIV-1 isolated from patients on prolonged therapy.

Wainberg MA, Tremblay M, Rooke R, Fanning M, Tsoukas C, Montaner JS, O'Shaughnessy M, Ruedy J.

Drugs Exp Clin Res. 1992;18(7):283-90.

PMID:
1295721
20.

Aerosol pentamidine-induced bronchoconstriction. Predictive factors and preventive therapy.

Quieffin J, Hunter J, Schechter MT, Lawson L, Ruedy J, Paré P, Montaner JS.

Chest. 1991 Sep;100(3):624-7.

PMID:
1832372
21.

Clinical significance and characterization of AZT-resistant strains of HIV-1.

Wainberg MA, Rooke R, Tremblay M, Li X, Parniak MA, Gao Q, Yao XJ, Tsoukas C, Montaner J, Fanning M, Ruedy J.

Can J Infect Dis. 1991 Spring;2(1):5-11.

22.

Canadian multicenter azidothymidine trial: AZT pharmacokinetics.

Child S, Montaner J, Tsoukas C, Fanning M, Le T, Wall RA, Ruedy J.

J Acquir Immune Defic Syndr. 1991;4(9):865-70.

PMID:
1895207
23.
24.

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

Montaner JS, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J.

Ann Intern Med. 1990 Jul 1;113(1):14-20.

PMID:
2190515
25.

Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?

Ruedy J, Schechter M, Montaner JS.

Ann Intern Med. 1990 May 15;112(10):721-3. Review. No abstract available.

PMID:
1970465
26.

The effect of zidovudine on platelet count in HIV-infected individuals.

Montaner JS, Le T, Fanning M, Gelmon K, Tsoukas C, Falutz J, O'Shaughnessy M, Wainberg MA, Ruedy J.

J Acquir Immune Defic Syndr. 1990;3(6):565-70.

PMID:
2187071
27.

Validity and reproducibility of a screening examination for neurological abnormality in persons exposed to methylmercury.

McKeown-Eyssen GE, Ruedy J, Hogg S, Guernsey JR, Woods I.

J Clin Epidemiol. 1990;43(5):489-98.

PMID:
2182789
28.

A profile of academic physicians in British Columbia.

Barer ML, Kazanjian A, Pagliccia N, Ruedy J, Webber WA.

Acad Med. 1989 Sep;64(9):524-32.

PMID:
2765064
30.

Cessation of zidovudine therapy may lead to increased replication of HIV-1.

Wainberg MA, Falutz J, Fanning M, Gill J, Gelmon K, Montaner JS, O'Shaughnessy M, Tsoukas C, Ruedy J.

JAMA. 1989 Feb 10;261(6):865-6. No abstract available.

PMID:
2913381
31.

Clinical skills of medical residents: a review of physical examination.

Chan-Yan C, Gillies JH, Ruedy J, Montaner JS, Marshall SA.

CMAJ. 1988 Oct 1;139(7):629-32.

32.

Therapeutic implications of sodium abnormalities in hypertension.

Ruedy J.

Clin Invest Med. 1987 Nov;10(6):592-6. Review.

PMID:
2449991
33.

Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia.

Mayo W, Leighton K, Robertson B, Ruedy J.

Can J Anaesth. 1987 Jan;34(1):79-82.

PMID:
3829290
34.

Should calcium be used in cardiac arrest?

Hughes WG, Ruedy JR.

Am J Med. 1986 Aug;81(2):285-96. Review.

PMID:
3526886
35.

Treatment of Pseudomonas and Serratia infections with ceftazidime.

Bergin CJ, Phillips P, Chan RM, Ruedy J, Crichton EP.

J Antimicrob Chemother. 1985 May;15(5):613-21.

PMID:
3924882
36.

Teratogenic risk of drugs used in early pregnancy.

Ruedy J.

Can Fam Physician. 1984 Oct;30:2133-6.

37.

Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.

Stein HB, Ruedy J, Atkins CJ, Offer RC.

Clin Invest Med. 1984;7(1):59-63.

PMID:
6723126
38.

Methyl mercury exposure in northern Quebec. II. Neurologic findings in children.

McKeown-Eyssen GE, Ruedy J, Neims A.

Am J Epidemiol. 1983 Oct;118(4):470-9.

PMID:
6637974
39.

Methyl mercury exposure in northern Quebec. I. Neurologic findings in adults.

McKeown-Eyssen GE, Ruedy J.

Am J Epidemiol. 1983 Oct;118(4):461-9.

PMID:
6637973
40.

Calcium blockers for cardiac disease: therapeutic implications.

Dodek A, Ruedy J.

Can Med Assoc J. 1983 Apr 15;128(8):911-5. No abstract available.

41.

Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.

Stein HB, Ruedy J, Atkins CJ, Offer RC.

J Rheumatol. 1983 Apr;10(2):319-22.

PMID:
6864688
42.
43.

Nutritional status of Quebec Indians.

Hoffer J, Ruedy J, Verdier P.

Am J Clin Nutr. 1981 Dec;34(12):2784-9.

PMID:
7315780
44.

Verapamil.

Ruedy J.

Clin Invest Med. 1981;4(2):129-47. Review. No abstract available.

PMID:
7026099
45.

Labetalol in essential hypertension.

Larochelle P, Hamet P, Hoffman B, Kuchel O, McKenzie J, Mitenko P, Ogilvie RI, Ruedy J.

J Cardiovasc Pharmacol. 1980 Nov-Dec;2(6):751-9.

PMID:
6160325
46.

Acebutolol and hydrochlorothiazide in essential hypertension.

Nadeau J, Ogilvie RI, Ruedy J, Brossard JJ.

Clin Pharmacol Ther. 1980 Sep;28(3):296-301.

PMID:
7408389
47.

Antihypertensive efficacy of propranolol given twice daily.

MacLeod SM, Hamet P, Kaplan H, Larochelle P, Nadeau J, Ogilvie RI, Rangno RE, Ruedy J, Sellers EM, Ti TY.

Can Med Assoc J. 1979 Sep 22;121(6):737-40.

48.

Digoxin dosage in patients with gastric hyperacidity.

McGilveray IJ, Loo JC, Jordan N, Nattel S, Ruedy J.

Can Med Assoc J. 1979 Sep 22;121(6):704-5. No abstract available.

49.

Disposition of 5-fluorouracil during chronic hepatic arterial infusion to patients with carcinoma in the liver and effect on circulating platelets.

Sitar DS, Ruedy JR, Shaw DH Jr, Maksymiuk AW, Thirlwell MP.

Biopharm Drug Dispos. 1979 Jul-Sep;1(1):19-26.

PMID:
552857
50.

Physostigmine in coma due to drug overdose.

Nattel S, Bayne L, Ruedy J.

Clin Pharmacol Ther. 1979 Jan;25(1):96-102. No abstract available.

PMID:
363335

Supplemental Content

Support Center